Programmed cell death as a defence against infection

Nature Reviews Immunology

Volumn 17, Issue 3, 2017, Pages 151-164

  Jorgensen, Ine ^a   Rayamajhi, Manira ^b   Miao, Edward A ^c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Camargo Pharmaceutical Services   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 11; CASPASE 8; INFLAMMASOME; INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; PHOSPHOTRANSFERASE; PROTEIN; RIP KINASE 3; UNCLASSIFIED DRUG; Z DNA BINDING PROTEIN 1;

APOPTOSIS; BACTERIAL INFECTION; CELL DEATH; EXTRACELLULAR TRAP; HUMAN; INFECTION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NECROPTOSIS; NEUTROPHIL; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; PYROPTOSIS; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION; ANIMAL; IMMUNOLOGY;

ANIMALS; CELL DEATH; HUMANS; IMMUNITY, INNATE; INFECTION;

EID: 85010966276     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri.2016.147     Document Type: Review

References (180)

1. Fuchs, Y., Steller, H. Programmed cell death in animal development and disease. Cell 147, 742-758 (2011)
2. Taylor, R. C., Cullen, S. P., Martin, S. J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 9, 231-241 (2008)
3. Vanden Berghe, T., Hassannia, B., Vandenabeele, P. An outline of necrosome triggers. Cell. Mol. Life Sci. 73, 2137-2152 (2016)
4. Dillon, C. P., Tummers, B., Baran, K., Green, D. R. Developmental checkpoints guarded by regulated necrosis. Cell. Mol. Life Sci. 73, 2125-2136 (2016)
5. Dondelinger, Y., Darding, M., Bertrand, M. J. M., Walczak, H. Poly-ubiquitination in TNFR1-mediated necroptosis. Cell. Mol. Life Sci. 73, 2165-2176 (2016)
6. Jorgensen, I., Miao, E. A. Pyroptotic cell death defends against intracellular pathogens. Immunol. Rev. 265, 130-142 (2015)
7. Remijsen, Q., et al. Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ. 18, 581-588 (2011)
8. Lindgren, S. W., Stojiljkovic, I., Heffron, F. Macrophage killing is an essential virulence mechanism of Salmonella typhimurium. Proc. Natl Acad. Sci. USA 93, 4197-4201 (1996)
9. Miao, E. A., et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11, 1136-1142 (2010)
10. Dangl, J. L., Jones, J. D. G. Plant pathogens and integrated defence responses to infection. Nature 411, 826-833 (2001)
11. Mackey, D., Holt, B. F., Wiig, A., Dangl, J. L. RIN4 interacts with Pseudomonas syringae type III effector molecules and is required for RPM1-mediated resistance in Arabidopsis. Cell 108, 743-754 (2002)
12. Mackey, D., Belkhadir, Y., Alonso, J. M., Ecker, J. R., Dangl, J. L. Arabidopsis RIN4 is a target of the type III virulence effector AvrRpt2 and modulates RPS2-mediated resistance. Cell 112, 379-389 (2003)
13. Broz, P., Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407-420 (2016)
14. Kayagaki, N., et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117-121 (2011)
15. Hagar, J. A., Powell, D. A., Aachoui, Y., Ernst, R. K., Miao, E. A. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 341, 1250-1253 (2013)
16. Kayagaki, N., et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246-1249 (2013)
17. Shi, J., et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514, 187-192 (2014)
18. Aachoui, Y., et al. Caspase-11 protects against bacteria that escape the vacuole. Science 339, 975-978 (2013)
19. Aachoui, Y., et al. Canonical inflammasomes drive IFN-? to prime caspase-11 in defense against a cytosol-invasive bacterium. Cell Host Microbe 18, 320-332 (2015)
20. Kobayashi, T., et al. The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection. Cell Host Microbe 13, 570-583 (2013)
21. Shi, J., et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660-665 (2015)
22. Kayagaki, N., et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666-671 (2015)
23. He, W.-T., et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1? secretion. Cell Res. 25, 1285-1298 (2015)
24. Agard, N. J., Maltby, D., Wells, J. A. Inflammatory stimuli regulate caspase substrate profiles. Mol. Cell Proteom. 9, 880-893 (2010)
25. Saeki, N., Sasaki, H. Gasdermin superfamily: A novel gene family functioning in epithelial cells in Endothelium and Epithelium (eds Carrasco, J., Mota, M. ) 193-211 (2012)
26. Ding, J., et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111-116 (2016)
27. Aglietti, R. A., et al. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc. Natl Acad. Sci. USA 113, 7858-7863 (2016)
28. Liu, X., et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153-158 (2016)
29. Sborgi, L., et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 35, 1766-1778 (2016)
30. Hoffmann, E. K., Lambert, I. H., Pedersen, S. F. Physiology of cell volume regulation in vertebrates. Physiol. Rev. 89, 193-277 (2009)
31. McNeil, P. L., Kirchhausen, T. An emergency response team for membrane repair. Nat. Rev. Mol. Cell Biol. 6, 499-505 (2005)
32. Chen, X., et al. Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 26, 1007-1020 (2016)
33. Bergsbaken, T., Fink, S. L., Hartigh, den, A. B., Loomis, W. P., Cookson, B. T. Coordinated host responses during pyroptosis: caspase-1-dependent lysosome exocytosis and inflammatory cytokine maturation. J. Immunol. 187, 2748-2754 (2011)
34. Moltke, Von, J., et al. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490, 107-111 (2012)
35. Jorgensen, I., Lopez, J. P., Laufer, S. A., Miao, E. A. IL-1?, IL-18, and eicosanoids promote neutrophil recruitment to pore-induced intracellular traps following pyroptosis. Eur. J. Immunol. 46, 2761-2766 (2016)
36. Miao, E. A., et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl Acad. Sci. USA 107, 3076-3080 (2010)
37. Sauer, J.-D., et al. Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity. Proc. Natl Acad. Sci. USA 108, 12419-12424 (2011)
38. Warren, S. E., et al. Generation of a Listeria vaccine strain by enhanced caspase-1 activation. Eur. J. Immunol. 41, 1934-1940 (2011)
39. Maltez, V. I., et al. Inflammasomes coordinate pyroptosis and natural killer cell cytotoxicity to clear infection by a ubiquitous environmental bacterium. Immunity 43, 987-997 (2015)
40. Jorgensen, I., Zhang, Y., Krantz, B. A., Miao, E. A. Pyroptosis triggers pore-induced intracellular traps (PITs) that capture bacteria and lead to their clearance by efferocytosis. J. Exp. Med. 213, 2113-2128 (2016)
41. Mariathasan, S., Weiss, D. S., Dixit, V. M., Monack, D. M. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 202, 1043-1049 (2005)
42. Ceballos-Olvera, I., Sahoo, M., Miller, M. A., Del Barrio, L., Re, F. Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1? is deleterious. PLoS Pathog. 7, e1002452 (2011)
43. Aachoui, Y., Sagulenko, V., Miao, E. A., Stacey, K. J. Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection. Curr. Opin. Microbiol. 16, 319-326 (2013)
44. Maltez, V. I., Miao, E. A. Reassessing the evolutionary importance of inflammasomes. J. Immunol. 196, 956-962 (2016)
45. Sellin, M. E., et al. Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa. Cell Host Microbe 16, 237-248 (2014)
46. Knodler, L. A., et al. Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe 16, 249-256 (2014)
47. Rathinam, V. A. K., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11, 395-402 (2010)
48. Kerur, N., et al. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe 9, 363-375 (2011)
49. Doitsh, G., et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505, 509-514 (2014)
50. Monroe, K. M., et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 343, 428-432 (2014)
51. Jakobsen, M. R., et al. From the cover: IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc. Natl Acad. Sci. USA 110, E4571-E4580 (2013)
52. Upton, J. W., Kaiser, W. J., Mocarski, E. S. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11, 290-297 (2012)
53. Kuriakose, T., et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci. Immunol. 1, aag2045 (2016)
54. Thapa, R. J., et al. DAI senses influenza A virus genomic RNA and activates RIPK3-dependent cell death. Cell Host Microbe 20, 674-681 (2016)
55. Zhang, D.-W., et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332-336 (2009)
56. Cho, Y. S., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123 (2009)
57. He, S., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-?. Cell 137, 1100-1111 (2009)
58. Sun, L., et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213-227 (2012)
59. Murphy, J. M., et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443-453 (2013)
60. Dondelinger, Y., et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 7, 971-981 (2014)
61. Wang, H., et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 54, 133-146 (2014)
62. Cai, Z., et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 16, 55-65 (2014)
63. Tanzer, M. C., et al. Necroptosis signalling is tuned by phosphorylation of MLKL residues outside the pseudokinase domain activation loop. Biochem. J. 471, 255-265 (2015)
64. Nogusa, S., et al. RIPK3 activates parallel pathways of MLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza A virus. Cell Host Microbe 20, 13-24 (2016)
65. Newton, K., et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ. 23, 1565-1576 (2016)
66. Guo, H., et al. Herpes simplex virus suppresses necroptosis in human cells. Cell Host Microbe 17, 243-251 (2015)
67. Yu, X., et al. Herpes simplex virus 1 (HSV-1) and HSV-2 mediate species-specific modulations of programmed necrosis through the viral ribonucleotide reductase large subunit R1. J. Virol. 90, 1088-1095 (2016)
68. Huang, Z., et al. RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Cell Host Microbe 17, 229-242 (2015)
69. Wang, X., et al. Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense. Proc. Natl Acad. Sci. USA 111, 15438-15443 (2014)
70. Rodrigue-Gervais, I. G., et al. Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell Host Microbe 15, 23-35 (2014)
71. Lu, J. V., et al. Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc. Natl Acad. Sci. USA 108, 15312-15317 (2011)
72. Robinson, N., et al. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 13, 954-962 (2012)
73. Rayamajhi, M., Humann, J., Penheiter, K., Andreasen, K., Lenz, L. L. Induction of IFN- enables Listeria monocytogenes to suppress macrophage activation by IFN-. J. Exp. Med. 207, 327-337 (2010)
74. Philip, N. H., et al. Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-?B and MAPK signaling. Proc. Natl Acad. Sci. USA 111, 7385-7390 (2014)
75. Gurung, P., et al. FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J. Immunol. 192, 1835-1846 (2014)
76. Weng, D., et al. Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death. Proc. Natl Acad. Sci. USA 111, 7391-7396 (2014)
77. Kitur, K., et al. Necroptosis promotes Staphylococcus aureus clearance by inhibiting excessive inflammatory signaling. Cell Rep. 16, 2219-2230 (2016)
78. Kitur, K., et al. Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog. 11, e1004820 (2015)
79. Gonzlez-Juarbe, N., et al. Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLoS Pathog. 11, e1005337 (2015)
80. Poon, I. K. H., Lucas, C. D., Rossi, A. G., Ravichandran, K. S. Apoptotic cell clearance: basic biology and therapeutic potential. Nat. Rev. Immunol. 14, 166-180 (2014)
81. Lamkanfi, M., Dixit, V. M. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8, 44-54 (2010)
82. Robinson, K. S., Aw, R. The commonalities in bacterial effector inhibition of apoptosis. Trends Microbiol. 24, 665-680 (2016)
83. Zheng, J. H., Viacava Follis, A., Kriwacki, R. W., Moldoveanu, T. Discoveries and controversies in BCL-2 protein-mediated apoptosis. FEBS J. 283, 2690-2700 (2016)
84. Dewson, G., Kluck, R. M. Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J. Cell. Sci. 122, 2801-2808 (2009)
85. White, M. J., et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159, 1549-1562 (2014)
86. Rongvaux, A., et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 159, 1563-1577 (2014)
87. Silke, J., Hartland, E. L. Masters, marionettes and modulators: intersection of pathogen virulence factors and mammalian death receptor signaling. Curr. Opin. Immunol. 25, 436-440 (2013)
88. Kaiser, W. J., et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368-372 (2011)
89. Oberst, A., et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363-367 (2011)
90. Newton, K., et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343, 1357-1360 (2014)
91. Mandal, P., et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56, 481-495 (2014)
92. Rickard, J. A., et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175-1188 (2014)
93. Dillon, C. P., et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157, 1189-1202 (2014)
94. Kaiser, W. J., et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc. Natl Acad. Sci. USA 111, 7753-7758 (2014)
95. Lin, J., et al. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature 540, 124-128 (2016)
96. Newton, K., et al. RIPK1 inhibits ZBP1-driven necroptosis during development. Nature 540, 129-133 (2016)
97. Cusson-Hermance, N., Khurana, S., Lee, T. H., Fitzgerald, K. A., Kelliher, M. A. Rip1 mediates the Trif-dependent toll-like receptor 3-and 4-induced NF-?B activation but does not contribute to interferon regulatory factor 3 activation. J. Biol. Chem. 280, 36560-36566 (2005)
98. Meylan, E., et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-?B activation. Nat. Immunol. 5, 503-507 (2004)
99. Moriwaki, K., et al. The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. Immunity 41, 567-578 (2014)
100. Kang, S., et al. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat. Commun. 6, 7515 (2015)
101. Brinkmann, V., et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535 (2004)
102. Branzk, N., et al. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat. Immunol. 15, 1017-1025 (2014)
103. Clark, S. R., et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463-469 (2007)
104. Parker, H., Dragunow, M., Hampton, M. B., Kettle, A. J., Winterbourn, C. C. Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. J. Leukoc. Biol. 92, 841-849 (2012)
105. Papayannopoulos, V., Metzler, K. D., Hakkim, A., Zychlinsky, A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191, 677-691 (2010)
106. Yipp, B. G., et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat. Med. 18, 1386-1393 (2012)
107. Man, S. M., et al. Salmonella infection induces recruitment of caspase-8 to the inflammasome to modulate IL-1? production. J. Immunol. 191, 5239-5246 (2013)
108. Ganesan, S., et al. Caspase-8 modulates dectin-1 and complement receptor 3-driven IL-1? production in response to ?-glucans and the fungal pathogen Candida albicans. J. Immunol. 193, 2519-2530 (2014)
109. Allam, R., et al. Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming. EMBO Rep. 15, 982-990 (2014)
110. Kang, T.-B., Yang, S.-H., Toth, B., Kovalenko, A., Wallach, D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 38, 27-40 (2012)
111. Lopez-Castejon, G., et al. Deubiquitinases regulate the activity of caspase-1 and interleukin-1? secretion via assembly of the inflammasome. J. Biol. Chem. 288, 2721-2733 (2013)
112. Juliana, C., et al. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J. Biol. Chem. 287, 36617-36622 (2012)
113. Py, B. F., Kim, M.-S., Vakifahmetoglu-Norberg, H., Yuan, J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol. Cell 49, 331-338 (2013)
114. Lawlor, K. E., et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun. 6, 6282 (2015)
115. Cai, X., et al. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156, 1207-1222 (2014)
116. Lu, A., et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156, 1193-1206 (2014)
117. Pierini, R., et al. AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages. Cell Death Differ. 19, 1709-1721 (2012)
118. Sagulenko, V., et al. AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ. 20, 1149-1160 (2013)
119. Vajjhala, P. R., et al. The inflammasome adaptor ASC induces procaspase-8 death effector domain filaments. J. Biol. Chem. 290, 29217-29230 (2015)
120. LaRock, C. N., Cookson, B. T. The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing. Cell Host Microbe 12, 799-805 (2012)
121. Pierini, R., et al. ASC controls IFN-? levels in an IL-18-dependent manner in caspase-1-deficient mice infected with Francisella novicida. J. Immunol. 191, 3847-3857 (2013)
122. Maelfait, J., et al. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1? maturation by caspase-8. J. Exp. Med. 205, 1967-1973 (2008)
123. Bossaller, L., et al. Cutting edge: FAS (CD95) mediates noncanonical IL-1? and IL-18 maturation via caspase-8 in an RIP3-independent manner. J. Immunol. 189, 5508-5512 (2012)
124. Antonopoulos, C., et al. Caspase-8 as an effector andregulator of NLRP3 inflammasome signaling. J. Biol. Chem. 290, 20167-20184 (2015)
125. Vince, J. E., et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36, 215-227 (2012)
126. K?gi, D., Ledermann, B., B?rki, K., Hengartner, H., Zinkernagel, R. M. CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur. J. Immunol. 24, 3068-3072 (1994)
127. Laochumroonvorapong, P., et al. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun. 65, 127-132 (1997)
128. M?ller, A. A., et al. An NK cell perforin response elicited via IL-18 controls mucosal inflammation kinetics during Salmonella gut infection. PLoS Pathog. 12, e1005723-e1005730 (2016)
129. Solaymani-Mohammadi, S., et al. Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector molecules. J. Leukoc. Biol. 99, 475-482 (2016)
130. Walch, M., et al. Cytotoxic cells kill intracellular bacteria through granulysin-mediated delivery of granzymes. Cell 157, 1309-1323 (2014)
131. Dotiwala, F., et al. Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites. Nat. Med. 22, 210-216 (2016)
132. Fratazzi, C., Arbeit, R. D., Carini, C., Remold, H. G. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158, 4320-4327 (1997)
133. Behar, S. M., Divangahi, M., Remold, H. G. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat. Rev. Microbiol. 8, 668-674 (2010)
134. Martin, C. J., et al. Efferocytosis Is an Innate Antibacterial Mechanism. Cell Host Microbe 12, 289-300 (2012)
135. Yang, C.-T., et al. Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host Microbe 12, 301-312 (2012)
136. Hartman, M. L., Kornfeld, H. Interactions between na?ve and infected macrophages reduce Mycobacterium tuberculosis viability. PLoS ONE 6, e27972 (2011)
137. Czuczman, M. A., et al. Listeria monocytogenes exploits efferocytosis to promote cell-to-cell spread. Nature 509, 230-234 (2014)
138. Fujimoto, I., Pan, J., Takizawa, T., Nakanishi, Y. Virus clearance through apoptosis-dependent phagocytosis of influenza A virus-infected cells by macrophages. J. Virol. 74, 3399-3403 (2000)
139. Amara, A., Mercer, J. Viral apoptotic mimicry. Nat. Rev. Microbiol. 13, 461-469 (2015)
140. Urban, C. F., Reichard, U., Brinkmann, V., Zychlinsky, A. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell. Microbiol. 8, 668-676 (2006)
141. Menegazzi, R., Decleva, E., Dri, P. Killing by neutrophil extracellular traps: fact or folklore? Blood 119, 1214-1216 (2012)
142. Yipp, B. G., Kubes, P. NETosis: how vital is it? Blood 122, 2784-2794 (2013)
143. McDonald, B., Urrutia, R., Yipp, B. G., Jenne, C. N., Kubes, P. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 12, 324-333 (2012)
144. Lauth, X., et al. M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J. Innate Immun. 1, 202-214 (2009)
145. Nauseef, W. M., Kubes, P. Pondering neutrophil extracellular traps with healthy skepticism. Cell. Microbiol. 18, 1349-1357 (2016)
146. Beiter, K., et al. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr. Biol. 16, 401-407 (2006)
147. Seper, A., et al. Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleases. PLoS Pathog. 9, e1003614 (2013)
148. Mllerherm, H., et al. Yersinia enterocolitica-mediated degradation of neutrophil extracellular traps (NETs). FEMS Microbiology Letters 362, fnv192 (2015)
149. Juneau, R. A., Stevens, J. S., Apicella, M. A., Criss, A. K. A thermonuclease of Neisseria gonorrhoeae enhances bacterial escape from killing by neutrophil extracellular traps. J. Infect. Dis. 212, 316-324 (2015)
150. Hong, W., Juneau, R. A., Pang, B., Swords, W. E. Survival of bacterial biofilms within neutrophil extracellular traps promotes nontypeable Haemophilus influenzae persistence in the chinchilla model for otitis media. J. Innate Immun. 1, 215-224 (2009)
151. Fazli, M., et al. Regulation of biofilm formation in Pseudomonas and Burkholderia species. Environ. Microbiol. 16, 1961-1981 (2014)
152. Reid, S. D., et al. Streptococcus pneumoniae forms surface-attached communities in the middle ear of experimentally infected chinchillas. J. Infect. Dis. 199, 786-794 (2009)
153. Wartha, F., et al. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell. Microbiol. 9, 1162-1171 (2007)
154. Cole, J. N., et al. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. mBio 1, e00191 (2010)
155. Kockritz-Blickwede, von, M., Blodkamp, S., Nizet, V. Interaction of bacterial exotoxins with neutrophil extracellular traps: impact for the infected host. Front. Microbiol. 7, 402 (2016)
156. Carroll, L. Through the Looking-Glass, and What Alice Found There. (1871)
157. Stewart, M. K., Cookson, B. T. Evasion and interference: intracellular pathogens modulate caspase-dependent inflammatory responses. Nat. Rev. Microbiol. 14, 346-359 (2016)
158. Wiersinga, W. J., Currie, B. J., Peacock, S. J. Melioidosis. N. Engl. J. Med. 367, 1035-1044 (2012)
159. Khan, I., et al. Glanders in animals: a review on epidemiology, clinical presentation, diagnosis and countermeasures. Transbound Emerg. Dis. 60, 204-221 (2013)
160. Zhang, H., et al. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471, 373-376 (2011)
161. Dillon, C. P., et al. Survival function of the FADD-CASPASE-8-cFLIPL complex. Cell Rep. 1, 401-407 (2012)
162. Mu?oz-Planillo, R., et al. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142-1153 (2013)
163. Wen, H., Miao, E. A., Ting, J. P.-Y. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 39, 432-441 (2013)
164. R?hl, S., Broz, P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K+ efflux. Eur. J. Immunol. 45, 2927-2936 (2015)
165. Schmid-Burgk, J. L., et al. Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells. Eur. J. Immunol. 45, 2911-2917 (2015)
166. Wang, X., et al. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat. Immunol. 15, 1126-1133 (2014)
167. Brunette, R. L., et al. Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. J. Exp. Med. 209, 1969-1983 (2012)
168. Xu, H., et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 513, 237-241 (2014)
169. Zhao, Y., et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477, 596-600 (2011)
170. Kofoed, E. M., Vance, R. E. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477, 592-595 (2011)
171. Levinsohn, J. L., et al. Anthrax lethal factor cleavage of nlrp1 is required for activation of the inflammasome. PLoS Pathog. 8, e1002638 (2012)
172. Chavarr?a-Smith, J., Vance, R. E. Direct proteolytic cleavage of NLRP1B is necessary and sufficient for inflammasome activation by anthrax lethal factor. PLoS Pathog. 9, e1003452 (2013)
173. Ruckdeschel, K., et al. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. J. Immunol. 173, 3320-3328 (2004)
174. Han, K.-J., et al. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-?B activation and apoptosis pathways. J. Biol. Chem. 279, 15652-15661 (2004)
175. Kaiser, W. J., Offermann, M. K. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J. Immunol. 174, 4942-4952 (2005)
176. Lin, Y., Devin, A., Rodriguez, Y., Liu, Z. G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13, 2514-2526 (1999)
177. Feng, S., et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell. Signall. 19, 2056-2067 (2007)
178. Feoktistova, M., et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43, 449-463 (2011)
179. He, S., Liang, Y., Shao, F., Wang, X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl Acad. Sci. USA 108, 20054-20059 (2011)
180. Kaiser, W. J., et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J. Biol. Chem. 288, 31268-31279 (2013)